Antimicrobial peptides

References

• Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Micro. 2005;3:238–50.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 2012;32:143–71.
   PubMed Web of Science ®Google Scholar
• Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24:1551–7.
   PubMed Web of Science ®Google Scholar
• Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers. 2002;66:236–48.
   PubMed Web of Science ®Google Scholar
• Melo MN, Ferre R, Castanho RMA. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Micro. 2009;7:245–50.
   PubMed Web of Science ®Google Scholar
• Pokorny A, Almeida PFF. Kinetics of dye efflux and lipid flip-flop induced by d-lysin in phospholipid vesicles and the mechanism of graded release by amphipathic a-helical peptides. Biochemistry. 2004;43:8846–57.
   PubMed Web of Science ®Google Scholar
• Mecke A, Lee DK, Ramamoorthy A, Orr BG, Banaszak Holl MM. Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys J. 2005;89:4043–50.
   PubMed Web of Science ®Google Scholar
• El Jastimi R, Lafleur M. Nisin promotes the formation of non-lamellar inverted phases in unsaturated phosphatidylethanolamines. Biochim Biophys Acta. 1999;1418:97–105.
   PubMed Web of Science ®Google Scholar
• Boesze-Battaglia K, Schimmel RJ. Cell membrane lipid composition and distribution: implications for cell function and lessons learned from photoreceptors and platelets. J Exp Biol. 1997;200:2927–36.
   PubMed Web of Science ®Google Scholar
• Lugtenberg EJJ, Peters R. Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12. Biochim Biophys Acta. 1976;441:38–47.
   PubMed Web of Science ®Google Scholar
• Haest CW, de Gier J, den Kamp JA, Bartels P, van Deenen LL. Changes in permeability of Staphylococcus aureus and derived liposomes with varying lipid composition. Biochim Biophys Acta. 1972;255:720–33.
   PubMed Web of Science ®Google Scholar
• Ringstad L, Schmidtchen A, Malmsten M. Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. Langmuir. 2006;22:5042–50.
   PubMed Web of Science ®Google Scholar
• Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, et al. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother. 2005;49:316–22.
   PubMed Web of Science ®Google Scholar
• Sigurdadottir T, Andersson P, Davoudi M, Malmsten M, Schmidtchen A, Bodelsson M. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother. 2006;50:2983–9.
   Google Scholar
• Ringstad L, Andersson Nordahl E, Schmidtchen A, Malmsten M. Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. Biophys J. 2007;92:87–98.
   PubMed Web of Science ®Google Scholar
• Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother. 2009;53:593–602.
   PubMed Web of Science ®Google Scholar
• Ringstad L, Protopapa E, Lindholm-Sethson B, Schmidtchen A, Nelson A, Malmsten M. An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir. 2008;24:208–16.
   PubMed Web of Science ®Google Scholar
• Cornut I, Büttner K, Dasseaux JL, Dufourcq J. The amphipathic a-helix concept: application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than melittin. FEBS Letts. 1994;349:29–33.
   Google Scholar
• Jerala R. Synthetic lipopeptides: a novel class of anti-infectives. Expert Opin Investig Drugs. 2007;16:1159–69.
   PubMed Web of Science ®Google Scholar
• Avrahami D, Shai Y. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry. 2002;41:2254–63.
   PubMed Web of Science ®Google Scholar
• Eeman M, Francius G, Dufren YF, Nott K, Paquot M, Deleu M. Effect of cholesterol and fatty acids on the molecular interactions of fengycin with stratum corneum mimicking lipid monolayers. Langmuir. 2009;25:3029–39.
   Google Scholar
• Schmidtchen A, Pasupuleti M, Mörgelin M, Davoudi M, Alenfall J, Chalupka A, et al. Boosting antimicrobial peptides by hydrophobic oligopeptide end-tags. J Biol Chem. 2009;284:17584–94.
   PubMed Web of Science ®Google Scholar
• Schmidtchen A, Ringstad L, Kasetty G, Mizuno H, Rutland MW, Malmsten M. Membrane selectivity by W-tagging of antimicrobial peptides. Biochim Biophys Acta. 2011;1808:1081–91.
   Google Scholar
• Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A. Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One. 2011;6:e16400.
   PubMed Web of Science ®Google Scholar
• Mouritsen OG, Zuckermann MJ. What's so special about cholesterol? Lipids. 2004;39:1101–13.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Schmidtchen A, Chalupka A, Ringstad L, Malmsten M. End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One. 2009;4:e5285.
   Google Scholar
• Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol. 2006;8:11–26.
   PubMed Web of Science ®Google Scholar
• Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 2001;193:1067–76.
   PubMed Web of Science ®Google Scholar
• Giuliani A, Pirri G, Nicoletto SF. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol. 2007;2:1–33.
   Web of Science ®Google Scholar
• Pranting M, Negrea A, Rhen M, Andersson DI. Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob Agents Chemother. 2008;52:2734–41.
   Google Scholar
• Pranting M, Andersson DI. Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2. J Antimicrob Chemother. 2010;65:876–87.
   PubMed Web of Science ®Google Scholar
• Lofton H, Pränting M, Thulin E, Andersson DI. Mechanism and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL and wheat germ histones. PLoS One. 2013;8:e68875.
   PubMed Web of Science ®Google Scholar